Clinical Trial Update: Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating huperzine A for hypertensive cerebral hemorrhage; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Cerebral Hemorrhage

Drugs mentioned

• Huperzine A (Huperzine A)

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Neurosensory Disorder | Phase 4 | Status: UNKNOWN